CDW
CDW
$137.25
+2.78%
CDW Corporation is a leading multi-brand provider of information technology (IT) solutions, offering hardware, software, and integrated services to businesses, government, education, and healthcare customers across the United States, the United Kingdom, and Canada. As a Fortune 500 company, CDW distinguishes itself through its extensive product portfolio, deep vendor partnerships, and value-added services such as cloud, security, and hybrid infrastructure solutions, positioning it as a one-stop shop for IT needs. The current investor narrative centers on the company's ability to navigate a challenging demand environment, with recent earnings highlighting strong revenue growth but compressed margins, while the stock has experienced significant volatility amid concerns about profitability and the broader macroeconomic backdrop. Additionally, CDW's strategic focus on AI-driven solutions and digital transformation services is seen as a key growth catalyst, though investors remain cautious about near-term cost pressures and the pace of recovery in enterprise IT spending.…
CDW
CDW
$137.25
Related headlines
Investment Opinion: Should I buy CDW Today?
Based on the analysis, CDW is rated a Buy. The consensus recommendation is 'Buy' with an average target price of $155.89, implying a 13.6% upside. The thesis is that CDW's accelerating revenue growth (9.25% YoY) and attractive forward PE of 11.5x offer a favorable risk/reward, provided margins stabilize. Key supporting data include a trailing PE of 16.75x, a PS ratio of 0.80x, and a net margin of 4.76%, which are reasonable relative to peers. The company's ROE of 40.9% and FCF of $1.08B underscore its profitability. The main risks are margin compression and high debt; if gross margins fall below 20% or revenue growth decelerates below 5%, the thesis would be invalidated. Overall, CDW appears undervalued relative to its growth prospects, but investors should monitor margin trends closely.
Sign up to view all
CDW 12-Month Price Forecast
The AI model assesses CDW as neutral, balancing strong revenue momentum and low forward PE against margin erosion and high leverage. The stock's recent 23.8% 3-month gain suggests improving sentiment, but the 1-year underperformance indicates lingering concerns. To upgrade to bullish, we would need to see gross margin stabilization above 21% and sustained revenue growth above 8%. Conversely, a downgrade to bearish would occur if margins fall below 20% or revenue growth drops below 5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CDW's 12-month outlook, with a consensus price target around $155.89 and implied upside of +13.6% versus the current price.
Average Target
$155.89
0 analysts
Implied Upside
+13.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$123 - $171
Analyst target range
CDW is covered by 9 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.8 (where 1 is Strong Buy and 5 is Sell). The average target price is $155.89, implying an upside of approximately 13.6% from the current price of $137.25. The distribution shows a bullish tilt, with no Sell ratings and a majority of Buy or Overweight ratings, reflecting confidence in the company's long-term prospects despite recent headwinds. The target range spans from a low of $123.00 to a high of $171.00, with the high target representing a 24.6% upside and the low target a 10.4% downside, indicating a moderate level of uncertainty. Recent institutional actions show a mix of upgrades and neutral stances, with Morgan Stanley and JP Morgan upgrading to Overweight in June and May 2026, respectively, while Citigroup has maintained a Neutral rating, suggesting that sentiment is improving but not uniformly bullish.
Bulls vs Bears: CDW Investment Factors
CDW presents a mixed picture: strong revenue acceleration and attractive forward multiples are countered by margin erosion and high leverage. The bull case hinges on sustained IT spending and margin recovery, while the bear case focuses on profitability pressures and a leveraged balance sheet. Currently, the bearish evidence is slightly stronger given the recent margin decline and stock underperformance, but the low forward PE and analyst upgrades provide a compelling value proposition. The key tension is whether CDW can expand margins back to historical levels (22%+) while maintaining double-digit revenue growth, which would justify the current valuation and drive the stock higher.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 9.25% YoY to $5.68B, accelerating from 6.4% in Q4 2025, marking the third consecutive quarter of faster growth. This momentum is driven by strong hardware and software demand, indicating a robust IT spending cycle.
- Attractive Forward Valuation: The forward PE of 11.5x is significantly below the trailing PE of 16.75x, implying the market expects ~45% EPS growth. This low multiple, relative to the broader market, offers a margin of safety if growth materializes.
- Analyst Consensus Buy with Upside: With a consensus rating of 'Buy' (mean score 1.8) and an average target price of $155.89, the stock implies a 13.6% upside. No sell ratings and recent upgrades from Morgan Stanley and JP Morgan signal improving sentiment.
- Strong Profitability Metrics: ROE stands at a robust 40.9%, and operating margin is 7.4%, reflecting efficient capital use and operational discipline. Free cash flow TTM is $1.08B, providing ample liquidity for dividends and debt reduction.
Bearish
- Margin Compression Threatens Earnings: Gross margin fell to 20.95% in Q1 2026 from 22.76% in Q4 2025, a 181 bps drop, driven by higher costs and competitive pricing. This pressure could persist, limiting EPS growth despite revenue acceleration.
- High Debt-to-Equity Ratio: Debt-to-equity stands at 2.43x, indicating significant leverage. Rising interest rates could increase interest expenses (Q1 interest expense was $55.3M), squeezing net income and reducing financial flexibility.
- Underperformance vs. Market: CDW's 1-year return is -16.4% versus the S&P 500's +20.5%, a 36.9% relative underperformance. This reflects persistent selling pressure and a lack of investor confidence, which may continue.
- Elevated PEG Ratio Signals Overvaluation: The PEG ratio of 19.3x suggests the stock is overvalued relative to its growth rate, as the market may be pricing in overly optimistic future earnings. This could lead to multiple compression if growth disappoints.
CDW Technical Analysis
CDW's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -16.4%, significantly underperforming the S&P 500's +20.5% gain. The current price of $137.25 sits at approximately 62% of its 52-week range (between $97.12 low and $171.55 high), indicating that the stock is trading closer to its lows than its highs, reflecting persistent selling pressure and a lack of investor conviction. This positioning suggests that while the stock is not at extreme oversold levels, it remains in a bearish phase, with any recovery likely to face resistance at higher levels.
Beta
0.94
0.94x market volatility
Max Drawdown
-45.5%
Largest decline past year
52-Week Range
$97-$172
Price range past year
Annual Return
-16.4%
Cumulative gain past year
| Period | CDW Return | S&P 500 |
|---|---|---|
| 1m | +5.7% | +3.6% |
| 3m | +23.8% | +2.7% |
| 6m | +10.1% | +11.4% |
| 1y | -16.4% | +18.7% |
| ytd | +3.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CDW Fundamental Analysis
CDW's revenue trajectory has been robust, with the most recent quarter (Q1 2026) reporting revenue of $5.68 billion, a 9.25% year-over-year increase, accelerating from the prior quarter's 6.4% growth (Q4 2025 revenue of $5.51 billion). This marks the third consecutive quarter of accelerating growth, driven by strength in hardware and software products, though services revenue remains a smaller component. The growth is broad-based, with the Corporate segment leading, but the company faces margin pressure as gross margin contracted to 20.95% in Q1 2026 from 22.76% in Q4 2025, reflecting higher costs and a competitive pricing environment.
Quarterly Revenue
$5.7B
2026-03
Revenue YoY Growth
+9.3%
YoY Comparison
Gross Margin
20.9%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CDW Overvalued?
Given CDW's positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE stands at 16.75x, while the forward PE is 11.50x, indicating that the market expects significant earnings growth over the next year. The gap between trailing and forward PE suggests an anticipated EPS increase of approximately 45%, which aligns with the company's recent growth acceleration and margin recovery expectations. This forward multiple is attractive relative to the broader market, but it hinges on the company's ability to expand margins and sustain revenue growth.
PE
16.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 16x~29x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant, with a debt-to-equity ratio of 2.43x indicating high leverage. Interest expenses of $55.3M in Q1 2026 could rise if rates stay elevated, pressuring net income. Gross margin contracted to 20.95% from 22.76% in Q4 2025, a 181 bps drop, reflecting cost pressures that could persist. Free cash flow of $1.08B provides some cushion, but the high payout ratio (30.8%) limits reinvestment. Revenue concentration in hardware and software exposes CDW to cyclical IT spending, which could slow if the economy weakens.
FAQ
The key risks are: 1) Financial: high debt-to-equity (2.43x) and rising interest expenses could pressure earnings. 2) Operational: gross margin contraction (down 181 bps in Q1) may persist, reducing profitability. 3) Market: the stock has underperformed the S&P 500 by 36.9% over the past year, indicating weak investor sentiment. 4) Macro: economic downturns could reduce IT spending, impacting revenue growth. The most severe risk is a combination of margin compression and a recession, which could lead to a 10-20% downside.
The 12-month forecast is moderately bullish, with a base case target of $140-$155 (50% probability), a bull case of $155-$171 (30% probability), and a bear case of $120-$130 (20% probability). The most likely scenario is the base case, where revenue growth continues but margins stabilize, leading to a modest upside to the average target of $155.89. The key assumption is that gross margins hold above 21% and IT spending remains resilient.
CDW appears undervalued on a forward PE basis (11.5x) relative to its growth, but the PEG ratio of 19.3x suggests overvaluation if growth slows. The trailing PE of 16.75x is in line with historical averages, while the PS ratio of 0.80x is attractive. The market is pricing in significant earnings growth (45% expected), which may be optimistic given margin pressures. Overall, the stock is fairly valued to slightly undervalued, but the high PEG warrants caution.
CDW is a good buy for investors seeking a growth stock at a reasonable valuation, given its forward PE of 11.5x and analyst upside of 13.6%. The stock has strong revenue momentum (9.25% YoY growth) and a consensus 'Buy' rating. However, the high debt-to-equity ratio (2.43x) and recent margin compression (gross margin down to 20.95%) introduce risk. It is a good buy for those who believe margins will stabilize and IT spending remains robust, but not for risk-averse investors.
CDW is better suited for long-term investment (3-5 years) given its growth trajectory and low forward PE. The stock's beta of 0.94 indicates moderate volatility, and its dividend yield of 1.84% provides some income. Short-term trading is possible given the recent 23.8% 3-month gain, but the stock's 1-year underperformance suggests it may be volatile. For long-term investors, the key is to monitor margin recovery and debt reduction; a minimum holding period of 3 years is recommended to ride out cyclicality.